Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M.A. Abdelrahim is active.

Publication


Featured researches published by M.A. Abdelrahim.


Tropical Doctor | 2018

Breaking bad news from the doctors’ perspective in a paternalistic society: the case of Sudan

Mohamed Siddig Eltayeb Muneer; Ahmed Elhassan; Ahmed Mohammed Abdulrahman Osman; Abdelmohaymin A. Abdalla; M.A. Abdelrahim; Suad M Ali; Ihab B Abdalrahman

Breaking bad news is a global challenge for all types of health providers. Our study assessed the attitude and practice from the doctors’ perspective in a patriarchal society. A descriptive cross-sectional hospital-based study was conducted, involving doctors from both medical and surgical departments. Almost half of the respondents believed that Sudanese patients do not like to know their diagnosis, and a slightly higher proportion had no previous training on how to break bad news. Some 20% indicated that they would conceal the diagnosis from a patient if his or her relatives so requested. Less than one-quarter of respondents followed a standard protocol. Although most of the doctors subscribed to the notion that patients have the right to know everything about their illnesses, not all of them held this attitude towards their local patient population.


F1000Research | 2017

In silico analysis of single nucleotide polymorphisms (SNPs) in human FOXC2 gene

Mohammed Nimir; Mohanad Abdelrahim; M.A. Abdelrahim; Mahil Abdalla; Wala eldin Ahmed; Muhanned Abdullah; Muzamil Mahdi Abdel Hamid

Introduction: Lymphedema is an abnormal accumulation of interstitial fluid, due to inefficient uptake and reduced flow, leading to swelling and disability, mostly in the extremities. Hereditary lymphedema usually occurs as an autosomal dominant trait with allelic heterogeneity. Methods: We identified single nucleotide polymorphisms (SNPs) in the FOXC2 gene using dbSNP, analyzed their effect on the resulting protein using VEP and Biomart, modelled the resulting protein using Project HOPE, identified gene – gene interactions using GeneMANIA and predicted miRNAs affected and the resulting effects of SNPs in the 5’ and 3’ regions using PolymiRTS. Results: We identified 473 SNPs - 429 were nsSNPs and 44 SNPs were in the 5’ and 3’ UTRs. In total, 2 SNPs - rs121909106 and rs121909107 - have deleterious effects on the resulting protein, and a 3D model confirmed those effects. The gene – gene interaction network showed the involvement of FOXC2 protein in the development of the lymphatic system. hsa-miR-6886-5p, hsa-miRS-6886-5p, hsa-miR-6720-3p, which were affected by the SNPs rs201118690, rs6413505, rs201914560, respectively, were the most important miRNAs affected, due to their high conservation score. Conclusions: rs121909106 and rs121909107 were predicted to have the most harmful effects, while hsa-miR-6886-5p, hsa-miR-6886-5p and hsa-miR-6720-3p were predicted to be the most important miRNAs affected. Computational biology tools have advantages and disadvantages, and the results they provide are predictions that require confirmation using methods such as functional studies.


Archive | 2015

In silico analysis of non-synonymous Single nucleotide polymorphisms of BMBR2 (PPH1) gene and demonstration of gene's network interactions

Mohamed Dafaalla; Mohamed Nasr Elsheikh; Mohamed Abdelrahim; Mohamed Adel Taha; Sundos Ahmed; Radowan Elnair; Enas Basher; Amro Abdelghani; Abdelmoneim Mohamed Ali; Musaab M. alfaki; M.A. Abdelrahim; Abdelmohaymin A. Abdalla; Musab I. Mohammed; Abbasher Hussein; Mohamed Salih Hassan

A major challenge for bringing safe and effective new treatment to patients is the deep understanding of a disease. Here, we describe the integration of multi-omics data with systems biology algorithms for tackling three milestones in the drug development process: Construction of pathways and comparison between normal or diseased cells; Identification of drug mode of action (MoA) and Prediction of drug toxicity and efficacy. On the experimental front, we develop custom multiplex proteomic and phosphoproteomic assays based on the Luminex technology. To guarantee the quality of the assays we quantify the cross-reactivity profile of antibodies and we have developed optimization algorithms to select the optimal pairs. Currently, a ~40x phosphoprotein panel and a ~80x cytokine panel have been developed. On the computational front, signaling cascades are modeled with a Boolean or fuzzy logic framework and signaling pathways or optimized in order to fit the phopshoproteomic data at hand. Then, knowing the cells topology, we monitor drug-induced topology alterations in order to reveal drug mode of action. Subsequently, supervised machine learning algorithms was able to select MoAs with reduced toxicity and increased efficacy. So far we have applied our approach in several diseases including liver cancer, osteoarthritis and multiple sclerosis.N syndrome is a nonspecific kidney disorder characterized by a number of signs of disease: Proteinuria, hypoalbuminemia and edema. It is characterized by an increase in permeability of the capillary walls of the glomerulus leading to the presence of high levels of protein in the urine. NPHS2 is encoding Podocin an important protein in renal filtration function. Analysis of the genetic variation that can alter the expression and the function of the NPHS2 gene was done using computational methods. Genomic analysis of NPHS2 was initiated by Sift and Polyphen-2 servers and yielded 18 mutations to be damaging , the mutant amino acids biophysical characteristics and multiple sequence alignment were demonstrated to be affecting the protein function using AlignGVGD and Panther platforms. 11 mutations affected protein function the most. Genetic co-expression profile and interactions were demonstrated by GeneMANIA server, and NPHS2 is found to be co-expressed with a neuronal protein, 3D structure molding was done using Phyre2 and Chimera. Computational methods yield accurate results which can be a basis of diagnosis of steroid resistant nephrotic syndrome.M syndrome is a common autosomal dominant hereditary connective tissue disorder with variable presentations, mutations in FBN1 gene were found to be responsible for Marfan syndrome and other relate connective tissue disorders. SNPs contributes to gene mutations and expression variations justifying phenotypic variations among patients and hence such SNPs would be potential target for identification and analysis which may help in early diagnosis of such life threatening disorder. Computational methods were used on this work focusing on analysis of SNPs in the coding regions of FBN1 gene found as non-synonymous variants (nsSNP) and those in the 3’un-translated regions (3’UTR) affecting miRNA binding using computational methods including SIFT and polyphen for analysis of (nsSNPs) while (3’UTR) SNPs was analyzed using PolymiRTS tool functions and Interactions of FBN1 gene with functional similar genes was predicted using gene MANIA software. Out of 1134 ns-SNPs analyzed, 38 SNPs were found to damaging while analysis of 175 SNP in 3’UTR prove that 24 SNPs are disturbing to their target sites and 46 SNPs are creating to new target sites. Using the damaging ns-SNPs predicted on this work may be helpful in early diagnosis and on screening of FBN1 related disorders.Mutations in BMPR2 gene are seen in about 15% of sporadic cases and about 40% of familial cases of PPH. We have studied non-synonymous SNPs in BMPR2-002 (ENST00000374574). Non-synonymous dsSNPs were identified using NCBI-database. Then advanced bioinformatics analysis was used to determine the functionality of each SNP in the coding region. Out of 323 SNPs which were found in the coding region, only 7 were found to be damaging in both SIFT and polyphen. 53 SNPs in 3UTR region were found to disrupt miRNA binding sites, whereas 55 SNPs were found to create new ones. Certain SNPs affect binding sites of certain MicroRNAs that have been linked to hepatic cancer and prostate cancer. BMPR2 gene interactions with other genes were identified and classified according to multiple parameters (physical interaction, co-localization, co-expression, pathway and prediction). BMPR2 is an important regulator in BMP pathway which affects cellular growth. Certain SNPs were found to affect BMPR2 structure hence function for better correlation with clinical cases.H tear fluid is a complex mixture containing high concentrations of proteins and is increasingly becoming an important source for studying protein composition of eye-related diseases. An important part of proteomic research is accurate quantification of proteins and this has made the incorporation of differentially stable isotopes in samples widely used. Dimethyl labeling at peptide level is a cost-effective, undemanding and fast labeling procedure that is applicable to nearly any biological sample. In addition, this procedure is capable of labeling sub-microgram to milligrams of sample and all reagents are compatible with LC-MS analysis. Therefore, the aim of this study was to look into the suitability of stable isotope dimethyl labeling for quantitative proteomics on tear fluid. The tear proteins were extracted using a single unit filter-aided method for both sample handling and protein extraction from Schirmer strips. The peptides were reversely labeled with a light label and an intermediate label and mixed before LC-MS/ MS analysis. The different stable isotopically labeled peptides showed a known mass difference when looking into the MS specters. Additionally, a clear signal intensity difference between the differentially labeled peptides was observed. These results show that stable isotope dimethyl labeling of tear proteins is both possible and successful and may serve as an important quantification method for tear proteome.


Journal of the Neurological Sciences | 2015

The correlation between the neurological complications of rheumatoid arthritis with the disease activity and functional impairment (Disability)

Mohamed Dafaalla; H.A.A. Eltoum; M.A. Taha; M.A. Abdelrahim; M.I. Alfaki; M.M. Alfaki; R.A. Alsherif; M.A. Alnour; D.N. Osman; A. Hussein

Objectives: To identify the impact and predictors of the neurological complications of rheumatoid arthritis (RA) among Sudanese patients. Methodology: A case series study of 58 consecutive patients diagnosed as having RA at Omdurman teaching hospital rheumatology clinic was done. Patients have another possible etiology for the neurological manifestations were excluded. The doctors of rheumatology clinic examined the patients and the Clinical Disease Activity Index (CDAI) was calculated. A senior consultant neurologist objectively assessed the neurological complications of RA. The patients were interviewed using the Health Assessment Questionnaire (HAQ) to evaluate the functional impairment. Various statistical tests were used to assess any possible association between various variables obtained. Results: Almost 60% have neurological signs (pyramidal system signs 43.1%, proximal weakness 8.6%, sensorimotor neuropathy 5.2%, pure sensory neuropathy 1.7%, extrapyramidal/cerebellar 0%). The mean HAQ scores for patients who express neurological signs and those who don’t express are 1.34 and 1.40 respectively without significant difference (P = 0.778). The association between the neurological complications and disease activity, ESR value, and rheumatoid factor status is not significant (P = 0.701, 0.515, 0.299 respectively). There is not only a strong association between the disease activity (CDAI) of RA and functional status (HAQ) of the patient (P = 0.0, R = 0.56), but also 30% of variability of the functional impairment can be attributed exclusively to the variability of the disease activity (R2 = 0.3). Conclusion: The RA activity is the major determinant of disease morbidity. The functional impairment caused by the neurological complications is negligible. The disease activity, ESR value, and rheumatoid factor status are poor predictors of the neurologic complications.


BMC Medical Genetics | 2017

Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer

Alsmawal Awad Mohammed Elimam; Mohamed Elmogtba Mouaweia Mohamed Aabdein; Mohamed El-Fatih Moly Eldeen; Hisham N. Altayb; Mohamed Adel Taha; Mohammed Nimir; Mohamed Dafaalla; Musaab M. alfaki; M.A. Abdelrahim; Abdelmohaymin A. Abdalla; Musab I. Mohammed; Mona Ellaithi; Muzamil Mahdi Abdel Hamid; Mohamed Salih Hassan


Sudan journal of medical sciences | 2018

Tutors, The Valuable Resource to Enhance Medical Students’ Motivation.

Mohamed Nasr Elsheikh; Reem Khalil; Alsarah Mutwakil Abbas Diab; Rayyan Abdalnabi; Mohamed Siddig Eltayeb Muneer; Ahmed Elhassan; Fadwa Mohammed; Shimaa Mahalah; Amna Khairy; Shahd Abdalnabi; Salma Shammet; Islam Ahmed Munier; Ragda Abdallah; M.A. Abdelrahim; Najla Basheer Ahmed Mohammed; Nazik Elmalaika Husain; Siham Ahmed Balla; Magda Elhadi


Sudan journal of medical sciences | 2018

Knowledge, attitude and practice of hepatitis (B) among healthcare workers in relation to their vaccination status in Khartoum, Sudan, 2015: a cross-sectional study

Almustafa Siddig Mohammed Mustafa; Almegdad Sharafaldin Mohamed Ahmed; Tariq Ahmed Abdelbaset Alamin; Mutaz Tarig HassanAhmed Shaheen; Awab Mohamed Mohamed Ahmed Hilali; Moneeb Hassan Mohammed Alamin Fadul; Ahmed Abdelaziz Abugrain Abdelsalam; M.A. Abdelrahim; Mohamed Nasr Elsheikh


Archive | 2017

In Silico Analysis of Single Nucleotide Polymorphisms (Snps) In Human FOXC2 Gene [Version 1; Referees: Awaiting Peer Review]

Mohammed Nimir; Mohanad Abdelrahim; M.A. Abdelrahim; Mahil Abdalla; Walaeldin Ahmed; Muhanned Abdullah; Muzamil Mahdi Abdelhamid


The Online Journal of Clinical Audits | 2016

Urinary catheters and quality control

Abdelmohaymin A. Abdalla; Ahmed El-Tahir Medani El-Shibly; Ahmed Mahgoub Sharif El Tohami; Mohamed SalahEldin Mohamed Ali; Raghda Hatim Abalhaleem Adlan; Mohamed Siddig Eltayeb Muneer; M.A. Abdelrahim; Ibrahim Jamal Mubarak Mohamed; Ihab B Abdalrahman


Journal of the Neurological Sciences | 2015

Association of medications adherence with the quality of life andcost of epilepsy among Sudanese epilepsy patients attending charity clinic

M.A. Abdelrahim; Mohamed Dafaalla; M.M. Alfaki; M.I. Alfaki; R.A. Alsherif; M.A. Taha; M.S. Ahmed; A.S. Ahmed; M.A. Alnour; A. Hussein

Collaboration


Dive into the M.A. Abdelrahim's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Hussein

University of Khartoum

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M.A. Taha

University of Khartoum

View shared research outputs
Top Co-Authors

Avatar

M.M. Alfaki

University of Khartoum

View shared research outputs
Top Co-Authors

Avatar

A.S. Ahmed

University of Khartoum

View shared research outputs
Top Co-Authors

Avatar

D.N. Osman

University of Khartoum

View shared research outputs
Top Co-Authors

Avatar

M.I. Alfaki

University of Khartoum

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge